Verzenio 100 mg/1
abemaciclib · TABLET · Eli Lilly and Company
No Recall History
Plain English
Verzenio is a tablet containing abemaciclib at 100 mg/1, taken oral. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Verzenio
- Generic Name
- abemaciclib
- NDC Code (Product)
0002-4815- Manufacturer
- Eli Lilly and Company
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208716
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 09/28/2017
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
diarrhoea5,680 reports
fatigue2,311 reports
nausea1,967 reports
vomiting1,055 reports
malignant neoplasm progression1,040 reports
decreased appetite875 reports
asthenia783 reports
death753 reports
drug ineffective714 reports
white blood cell count decreased655 reports
Frequently Asked Questions
What is Verzenio used for?
Verzenio contains abemaciclib. It is a tablet taken oral. Consult your doctor for specific uses.
Is Verzenio a controlled substance?
Verzenio is not classified as a controlled substance by the DEA.
What is the generic name for Verzenio?
The generic name for Verzenio is abemaciclib. There are no other listed brand versions of abemaciclib.
What is the NDC code for Verzenio 100 mg/1?
The NDC (National Drug Code) for Verzenio 100 mg/1 is 0002-4815, listed by Eli Lilly and Company.
Other Verzenio Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)